C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
Oncol Rep
; 18(1): 121-6, 2007 Jul.
Article
en En
| MEDLINE
| ID: mdl-17549356
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias de la Mama
/
Proteína p53 Supresora de Tumor
/
Receptor ErbB-2
/
Galectina 3
/
Recurrencia Local de Neoplasia
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Idioma:
En
Año:
2007
Tipo del documento:
Article